Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

[1]  R. Gilbertson,et al.  The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. , 2004, Brain research. Molecular brain research.

[2]  M. Scott,et al.  A Mouse Model for Medulloblastoma and Basal Cell Nevus Syndrome , 2001, Journal of Neuro-Oncology.

[3]  H. Hanafusa,et al.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  David J. Anderson,et al.  Deregulation of Dorsoventral Patterning by FGF Confers Trilineage Differentiation Capacity on CNS Stem Cells In Vitro , 2003, Neuron.

[5]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[6]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[7]  E. Holland,et al.  Using mice to decipher the molecular genetics of brain tumors. , 2003, Neurosurgery.

[8]  Heather L. Miller,et al.  A molecular fingerprint for medulloblastoma. , 2003, Cancer research.

[9]  T. Curran,et al.  Mouse embryos cloned from brain tumors. , 2003, Cancer research.

[10]  H. Wichterle,et al.  Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Ellison,et al.  What's new in neuro-oncology? Recent advances in medulloblastoma. , 2003, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[12]  Daniel H Turnbull,et al.  Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. , 2002, Cancer research.

[13]  Jussi Taipale,et al.  Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. , 2002, Genes & development.

[14]  A. Joyner,et al.  Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. , 2002, Development.

[15]  James M. Olson,et al.  Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.

[16]  J. Taipale,et al.  Patched acts catalytically to suppress the activity of Smoothened , 2002, Nature.

[17]  D. Ellison,et al.  Classifying the medulloblastoma: insights from morphology and molecular genetics , 2002, Neuropathology and applied neurobiology.

[18]  T. Jacks,et al.  Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.

[19]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[20]  M. Chintagumpala,et al.  Treatment controversies in medulloblastoma , 2001, Current opinion in oncology.

[21]  M. Scott,et al.  The developmental biology of brain tumors. , 2001, Annual review of neuroscience.

[22]  T. Curran,et al.  Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. , 2001, Cancer research.

[23]  M. Scott,et al.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine , 2000, Nature.

[24]  M. Scott,et al.  Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice , 2000, Genes, chromosomes & cancer.

[25]  A. Joyner,et al.  Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. , 2000, Development.

[26]  T. Curran,et al.  The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. , 2000, Cancer research.

[27]  M. Scott,et al.  Hedgehog and Patched in Neural Development and Disease , 1998, Neuron.

[28]  Y. Hirabayashi,et al.  An improved method for culturing cerebellar Purkinje cells with differentiated dendrites under a mixed monolayer setting. , 1998, Brain research. Brain research protocols.

[29]  T. Curran,et al.  Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. , 1998, Development.

[30]  P. Beachy,et al.  Teratogen-mediated inhibition of target tissue response to Shh signaling. , 1998, Science.

[31]  M. Scott,et al.  Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. , 1998, The Journal of investigative dermatology.

[32]  M. Wolter,et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1998, Cancer research.

[33]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[34]  M. Scott,et al.  Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. , 1997, Cancer research.

[35]  M. Nakafuku,et al.  A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. , 1997, Development.

[36]  A. Goldstein,et al.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. , 1997, American journal of medical genetics.

[37]  P. Kleihues,et al.  Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.

[38]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[39]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[40]  P. Brodal.  The Central Nervous System , 1992 .

[41]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[42]  Robert J. Gorlin,et al.  Nevoid Basal‐Cell Carcinoma Syndrome , 1987, Medicine.

[43]  R. Keeler,et al.  Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources. , 1968, Teratology.

[44]  S. Shapiro,et al.  An Analysis of Variance Test for Normality (Complete Samples) , 1965 .

[45]  W. Binns,et al.  A CONGENITAL CYCLOPIAN-TYPE MALFORMATION IN LAMBS INDUCED BY MATERNAL INGESTION OF A RANGE PLANT, VERATRUM CALIFORNICUM. , 1963, American journal of veterinary research.

[46]  W. Kruskal,et al.  Use of Ranks in One-Criterion Variance Analysis , 1952 .